Navigation Links
Luminex Corporation Receives Deloitte Technology Fast 500™ Award

AUSTIN, Texas, Oct. 19, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has been recognized in Deloitte's 2011 Technology Fast 500™, a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on comparing percentage revenue growth over five years from 2006-2010. 


"We are pleased to be included again in the Deloitte Technology Fast 500™ this year," said Patrick Balthrop, president and CEO of Luminex.  "Our revenue growth during this period is attributed to our pursuit of differentiated product offerings across diversified markets and channels.  This achievement signifies the hard work and dedication of our Luminex team, support from our loyal customers and strategic partners and our continued dedication to transforming global healthcare."

"Luminex Corporation, like all 2011 Technology Fast 500™ companies, has excelled in fostering innovation and channeling it into spectacular growth – against the backdrop of one of the most challenging economies in history," said Eric Openshaw, vice chairman and U.S. technology, media and telecommunications leader, Deloitte LLP.  "Deloitte recognizes Luminex for its remarkable accomplishment."

"We are pleased to honor Luminex as a 2011 Technology Fast 500™ company," said Mark Jensen, managing partner, technology and venture capital services, Deloitte & Touche LLP.  "As one of the fastest growing tech companies in North America, Luminex has demonstrated excellence in technological innovation, entrepreneurship, and rapid growth."

For more information about Luminex Corporation, please visit our web site at

About Deloitte's 2011 Technology Fast 500™ Technology Fast 500, which was conducted by Deloitte & Touche LLP, a subsidiary of Deloitte LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies – both public and private – in North America.  Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2006 to 2010.  In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues.  Companies must have base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD.  Additionally, companies must be in business for a minimum of five years, and be headquartered within North America.  More information on 2011 winners of the Deloitte Technology Fast 500 Program is available at

About Luminex Corporation Luminex is committed to applying its passion for innovation to advancing healthcare and research worldwide. We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP® open-architecture, multi-analyte platform, and our MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Our technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. We are meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology please visit our website at Corporate:

Harriss T. Currie

Chief Financial Officer and Vice President, Finance

Luminex Corporation



Mimi Torrington

Director, Marketing Communications

Luminex Corporation  

512.219.8020 Investors:

Matthew Scalo

Sr. Director, Investor Relations

Luminex Corporation


Leslie Denson

Porter Novelli


SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
2. Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
3. Luminex Corporation to Present at Upcoming Investment Conferences In September
4. Luminex Corporation Reports Second Quarter 2011 Results
5. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
6. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
7. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
8. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
9. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
10. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
11. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
Post Your Comments:
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
(Date:11/26/2015)... , November 26, 2015 3D bioprinting ... 2022, according to a new report by Grand View Research ... Disease (CKD) which demands kidney transplantation is expected to boost ... effective substitute for organ transplantation. --> 3D bioprinting ... 2022, according to a new report by Grand View Research ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
Breaking Medicine News(10 mins):